Plenty of supplement labels promise to "clear zombie cells." A new systematic review asked what human trials actually show, and the answer is less flattering to the pill aisle than the marketing suggests.
Researchers at the European Research Institute for the Biology of Ageing (ERIBA) in Groningen, including senescence researcher Marco Demaria, pooled the human interventional evidence on nutrition and cellular senescence. The review, published in Ageing Research Reviews, covers 29 articles describing 27 trials and 3,811 participants. Searches ran through September 2024.
The headline: calorie restriction produced the most consistent signal. Supplements were a distant, murkier second. The classic "senescent cell" markers mostly didn't budge.
First, what are "zombie cells"?
Senescent cells have permanently stopped dividing but don't die. They also release a mix of inflammatory and tissue-remodeling molecules known as the senescence-associated secretory phenotype, or SASP. Research has linked this to aging biology, which is why "senolytic" and "anti-senescence" products are so popular.
The catch is measurement. You can't easily count senescent cells in a living person, so trials rely on stand-in biomarkers. The review looked at several kinds:
- Cell-cycle arrest markers such as CDKN2A/p16 and CDKN1A/p21
- DNA damage markers
- Telomere length
- Transcriptomic (gene-expression) signatures
- SASP-related factors, mostly circulating inflammatory molecules
Calorie restriction took the lead
Among all nutritional strategies, calorie restriction produced the most recurrent reductions in circulating inflammatory and secretory factors commonly found in SASP panels. It also reduced senescence-associated transcriptomic signatures.
That is the strongest result in the review, and it matches what many aging researchers already suspected. Eating less appears to move senescence-linked inflammatory profiles in humans in a way that no supplement matched here.
The reductions were seen in SASP-type markers, not in a direct count of senescent cells. That distinction matters, as the section on limitations below explains.
The markers people love to cite? Mostly flat
Two of the most widely quoted aging readouts did poorly:
- p16 and p21, the classical cell-cycle arrest markers, were largely unchanged or highly variable across studies.
- Telomere length was also largely unchanged or highly variable.
If a product claims to "lengthen telomeres" or "lower p16" through diet or supplements, this review gives it little support in human intervention trials.
Metformin and rapamycin: it depends
The review also examined calorie restriction mimetics, drugs and compounds that act on similar pathways. Metformin and rapamycin showed context-dependent effects, most evident under metabolic or physiological stress.
That suggests they may matter most in people who already have a metabolic problem or a physiological challenge, not as a universal anti-aging switch for healthy people. Both are prescription drugs, so this is a conversation for a physician, not a shopping cart.
Omega-3: best supplement signal, with caveats
Of the dietary supplements, n-3 polyunsaturated fatty acids (omega-3s) looked most promising. They may modulate selected inflammatory and SASP-related circulating markers.
The authors were careful, though. They describe the supplement evidence overall as limited and heterogeneous. That means small or varied studies, different populations, and different markers, not a clear verdict.
Practical takeaways
What the evidence supports
- If you want to influence senescence-linked inflammatory signals, calorie restriction has the strongest human support in this review. The paper doesn't prescribe a specific protocol, so work out a safe approach with a clinician.
- If you're going to try one supplement for this reason, omega-3 has the best support. It is usually sold as fish oil, krill oil, or algal oil (a vegan option) containing EPA and DHA.
- The review doesn't establish an optimal omega-3 dose or form for senescence. Check the EPA and DHA content on the label, not just the total oil, and follow your clinician's guidance.
Who this might suit
- People already considering weight management or dietary changes, who can treat calorie restriction as one of the better-supported options.
- People who already have a reason to take omega-3 and want a modest, low-hype addition.
Who should skip or be cautious
- Anyone expecting a pill to "clear" senescent cells. This review doesn't show that.
- People who are underweight, pregnant, have a history of disordered eating, or have medical conditions. Calorie restriction isn't appropriate for everyone without supervision.
- People on blood thinners or with other medical conditions, who should talk to a doctor before starting high-dose fish oil.
- Anyone thinking of self-medicating with metformin or rapamycin. They are prescription drugs with context-dependent effects, and this review is not a green light.
The big caveat: these are signals, not proof
The authors stress that SASP factors and circulating cytokines are heterogeneous and not specific to senescent cells. Inflammation markers can fall for many reasons that have nothing to do with senescence, such as weight loss or lower general inflammation.
So the findings show possible modulation of senescence-associated markers, not definitive reductions in the number of senescent cells. The nutritional interventions appeared to affect inflammatory and secretory profiles more than the markers tied directly to how many senescent cells are present.
This review is also a synthesis of human trials, so its conclusions aren't animal or lab findings. But many of the claims behind "senolytic" supplements come from cell and rodent work, which the review doesn't evaluate.
What comes next
The authors call for multi-marker, functionally relevant endpoints in future clinical studies. In plain terms: measure several things at once and tie them to real health outcomes, rather than relying on one convenient blood marker.
Bottom line
No supplement in this review has been shown to clear zombie cells in humans. Calorie restriction has the best-supported effect on senescence-linked inflammatory signals. Omega-3 is the most promising supplement, with limited and uneven evidence. Telomere and p16 claims don't hold up in these trials.